Article Details

Vivos Therapeutics, Inc. (NASDAQ:VVOS) CEO Ronald Kirk Huntsman Acquires ... - Defense World

Retrieved on: 2022-06-04 12:28:45

Tags for this article:

Click the tags to see associated articles and topics

Vivos Therapeutics, Inc. (NASDAQ:VVOS) CEO Ronald Kirk Huntsman Acquires ... - Defense World. View article details on HISWAI: https://www.defenseworld.net/2022/06/04/vivos-therapeutics-inc-nasdaqvvos-ceo-ronald-kirk-huntsman-acquires-8000-shares.html

Excerpt

Two Sigma Investments LP bought a new position in Vivos Therapeutics in the third quarter valued at approximately $636,000.

Article found on: www.defenseworld.net

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up